15q Duplication Syndrome clinical trials at UC Health
1 in progress, 0 open to new patients
A Multicenter, Open-label, Pilot Study of TAK-935 (OV935) in Participants With 15Q Duplication Syndrome or CDKL5 Deficiency Disorder
Sorry, not currently recruiting here
The purpose of this study is to investigate the effect of TAK-935 (OV935) on the frequency of motor seizures for participants with 15q duplication syndrome or CDKL5 deficiency disorder throughout the Treatment Period (Titration and Maintenance).